InvestorsObserver
×
News Home

Is Anavex Life Sciences Corp (AVXL) Stock a Bad Value Thursday?

Thursday, November 30, 2023 12:04 PM | InvestorsObserver Analysts

Mentioned in this article

Is Anavex Life Sciences Corp (AVXL) Stock a Bad Value Thursday?

A rating of 63 puts Anavex Life Sciences Corp (AVXL) near the top of the Healthcare sector according to InvestorsObserver. Anavex Life Sciences Corp's score of 63 means that it ranks higher than 63% of stocks in the sector. In addition, its overall score of 29 ranks it higher than 29% of all stocks.

Overall Score - 29
AVXL has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on AVXL!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 29 means the stock is more attractive than 29 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Anavex Life Sciences Corp Stock Today?

Anavex Life Sciences Corp (AVXL) stock has gained 1.83% while the S&P 500 is lower by -0.16% as of 11:50 AM on Thursday, Nov 30. AVXL has risen $0.13 from the previous closing price of $7.09 on volume of 439,187 shares. Over the past year the S&P 500 is up 11.35% while AVXL is lower by -18.14%. AVXL lost -$0.60 per share the over the last 12 months. Click Here to get the full Stock Report for Anavex Life Sciences Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App